Novartis's Bexsero to be used in UK national program, subject to price
This article was originally published in Scrip
Executive Summary
Novartis's meningitis B vaccine Bexsero is to be included in the UK's national immunization program for babies aged 2-4 months, but will not be used for toddlers or adolescents.